Japan · Delayed Price · Currency is JPY Crasus Chemical Statistics
Total Valuation
Crasus Chemical has a market cap or net worth of JPY 48.95 billion. The enterprise value is 114.59 billion.
| Market Cap | 48.95B |
| Enterprise Value | 114.59B |
Important Dates
The next confirmed earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Crasus Chemical has 234.42 million shares outstanding.
| Current Share Class | 234.42M |
| Shares Outstanding | 234.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 10.84% |
| Float | 190.89M |
Valuation Ratios
The trailing PE ratio is 15.81.
| PE Ratio | 15.81 |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 37.01 |
| EV / Sales | 0.38 |
| EV / EBITDA | n/a |
| EV / EBIT | 18.49 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.09 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 6.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.07% |
| Return on Capital Employed (ROCE) | 5.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Crasus Chemical has paid 1.09 billion in taxes.
| Income Tax | 1.09B |
| Effective Tax Rate | 19.90% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 28,127,088 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Crasus Chemical had revenue of JPY 303.93 billion and earned 3.10 billion in profits. Earnings per share was 13.21.
| Revenue | 303.93B |
| Gross Profit | 21.11B |
| Operating Income | 4.21B |
| Pretax Income | 5.45B |
| Net Income | 3.10B |
| EBITDA | n/a |
| EBIT | 4.21B |
| Earnings Per Share (EPS) | 13.21 |
Balance Sheet
The company has 17.34 billion in cash and 52.46 billion in debt, with a net cash position of -35.12 billion or -149.84 per share.
| Cash & Cash Equivalents | 17.34B |
| Total Debt | 52.46B |
| Net Cash | -35.12B |
| Net Cash Per Share | -149.84 |
| Equity (Book Value) | 74.65B |
| Book Value Per Share | 284.12 |
| Working Capital | 9.50B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 6.95%, with operating and profit margins of 1.39% and 1.02%.
| Gross Margin | 6.95% |
| Operating Margin | 1.39% |
| Pretax Margin | 1.79% |
| Profit Margin | 1.02% |
| EBITDA Margin | n/a |
| EBIT Margin | 1.39% |
| FCF Margin | n/a |
Dividends & Yields
Crasus Chemical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 6.33% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Crasus Chemical has an Altman Z-Score of 1.77 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 1 |